- Home
- LGVN vs VSTD Comparison
LGVN vs VSTD Comparison
Compare LGVN & VSTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- VSTD
- Stock Information
- Founded
- LGVN 2014
- VSTD 2016
- Country
- LGVN United States
- VSTD United States
- Employees
- LGVN N/A
- VSTD N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- VSTD Restaurants
- Sector
- LGVN Health Care
- VSTD Consumer Discretionary
- Exchange
- LGVN Nasdaq
- VSTD Nasdaq
- Market Cap
- LGVN 17.6M
- VSTD 17.9M
- IPO Year
- LGVN 2021
- VSTD 2022
- Fundamental
- Price
- LGVN $0.83
- VSTD $0.78
- Analyst Decision
- LGVN Strong Buy
- VSTD
- Analyst Count
- LGVN 2
- VSTD 0
- Target Price
- LGVN $6.50
- VSTD N/A
- AVG Volume (30 Days)
- LGVN 553.9K
- VSTD 164.9K
- Earning Date
- LGVN 11-04-2025
- VSTD 11-18-2025
- Dividend Yield
- LGVN N/A
- VSTD N/A
- EPS Growth
- LGVN N/A
- VSTD N/A
- EPS
- LGVN N/A
- VSTD N/A
- Revenue
- LGVN $2,073,000.00
- VSTD $13,902,861.00
- Revenue This Year
- LGVN N/A
- VSTD N/A
- Revenue Next Year
- LGVN N/A
- VSTD N/A
- P/E Ratio
- LGVN N/A
- VSTD N/A
- Revenue Growth
- LGVN 68.67
- VSTD 30.39
- 52 Week Low
- LGVN $0.63
- VSTD $0.68
- 52 Week High
- LGVN $2.31
- VSTD $5.63
- Technical
- Relative Strength Index (RSI)
- LGVN 48.16
- VSTD N/A
- Support Level
- LGVN $0.75
- VSTD N/A
- Resistance Level
- LGVN $0.85
- VSTD N/A
- Average True Range (ATR)
- LGVN 0.05
- VSTD 0.00
- MACD
- LGVN 0.01
- VSTD 0.00
- Stochastic Oscillator
- LGVN 44.30
- VSTD 0.00
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About VSTD Vestand Inc. Class A Common Stock
Vestand Inc is a California-based Vestand is a fast-growing restaurant operator expanding into the real estate investment and development sector. It is a PropTech company engaged in AI-driven real estate investment and security token offerings (STOs). It provides services such as Property Acquisition, Property Development, Financial Management, and Property Management.